NY A09010

Requires practitioners to discuss risks of addiction, overdose, and dangerous drug interactions with patients (or parents/guardians of minors) before prescribing Schedule II controlled substances for pain or opioid drugs, and again before issuing a third prescription in a course of treatment

Mandates disclosure that opioids are highly addictive even when taken as prescribed, can cause physical or psychological dependence, and that mixing with alcohol, sedatives, or benzodiazepines can result in fatal respiratory depression

Requires practitioners to counsel patients on overdose risks and prescribe an opioid antagonist for the first opioid analgesic prescription of each calendar year exceeding a one-week supply when certain risk factors are present (history of substance use disorder, high doses of 90+ morphine milligram equivalents daily, or concurrent benzodiazepine use)

Exempts patients being treated for cancer, hospice/end-of-life care, post-surgical treatment immediately following a procedure, or medical emergencies from these requirements

Directs the Department of Health to develop and make available guidelines for practitioners on conducting the required risk discussions